Enhanced Enzyme Blend
Natural health product licensed in Canada
- Licence holder
- Avena Originals
- NPN or DIN-HM
- 80088724
- Status
- Active licence
- Licence date
- 15 October 2018
- Revision date
- 25 February 2019
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Protéase fongique Source : Aspergillus niger - En entier | 20 FCC SAPU | Not calculated |
| Protéase fongique Source : Aspergillus niger - En entier | 10 mg | Not calculated |
| 4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger - En entier | 10 Unités d'alpha-galactosidase du FCC | Not calculated |
| 4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger - En entier | 10 mg | Not calculated |
| 1,3-bêta-D-xylane xylanohydrolase Source : Aspergillus niger - En entier | 640 FCC HCU | Not calculated |
| 1,3-bêta-D-xylane xylanohydrolase Source : Aspergillus niger - En entier | 2 mg | Not calculated |
| bêta-galactosidase Source : Lactase | 500 FCC ALU | Not calculated |
| bêta-galactosidase Source : Lactase | 5 mg | Not calculated |
| myo-Inositol-hexakisphosphate 4-phosphohydrolase Source : Aspergillus niger - En entier | 50 FCC FTU | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 12 mg | Not calculated |
| bêta-D-fructofuranoside fructohydrolase Source : Saccharomyces cerevisiae - en entier | 400 Unités de sumner du FCC | Not calculated |
| bêta-D-fructofuranoside fructohydrolase Source : Saccharomyces cerevisiae - en entier | 2 mg | Not calculated |
Non-medicinal ingredients
Mélange de fruit et légume, Poudre d'enveloppes d'Oryza sativa (Riz), farine de riz
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Digestive enzymes. Digestive aid. Helps digest proteins.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If you have diabetes, consult a health care practitioner prior to use. If you have a gastrointestinal lesion/ulcer, are taking an anticoagulant/ blood thinner or an anti-inflammatory, or are having surgery, consult a health care practitioner prior to use.
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur; in such a case, discontinue use.
Source
Official Health Canada record, licence 80088724
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging